ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018

 

View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.


Pulmonary hypertension: therapy

Thematic Poster
Chairs: Z. Jing (Beijing, China), J. Weatherald (Calgary (AB), Canada), H. Olschewski (Graz, Austria), G. Simonneau (Le Kremlin-Bicêtre, France)
Pharmacokinetic (PK) interaction of fixed-dose combination (FDC) antiretrovirals (ARV) with riociguat (rio)
E. Dejesus (Florida, United States of America), S. Saleh (Wuppertal, Germany), D. Van Der Mey (Wuppertal, Germany), C. Becker (Wuppertal, Germany), R. Frey (Wuppertal, Germany), S. Unger (Wuppertal, Germany), W. Mueck (Wuppertal, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Clinical pharmacokinetic (PK) performance of a ralinepag extended-release (XR) tablet
J. Grundy (San Diego, United States of America), A. Blackburn (San Diego, United States of America), E. Parsley (San Diego, United States of America), Y. Tang (San Diego, United States of America), C. King (San Diego, United States of America), J. Adams (San Diego, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Inhaled liposomal iloprost shows high drug encapsulation, extended release profile and potentials of improving patient compliance
P. Kan (Taipei, Taiwan), . Chen (Taipei, Taiwan), C. Hsu (Taipei, Taiwan), Y. Lin (Taipei, Taiwan)
Congress or journal article abstract
Congress or journal article abstract
Acute response of iloprost inhalation using the Breelib nebulizer in pulmonary arterial hypertension: the Breelib acute study
M. Richter (Giessen, Germany), J. Axmann (Giessen, Germany), A. Ghofrani (Giessen, Germany), A. Rieth (Bad Nauheim, Germany), W. Seeger (Giessen, Germany), K. Tello (Giessen, Germany), H. Gall (Giessen, Germany)
Congress or journal article abstract
Congress or journal article abstract
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
R. Adão (Porto, Portugal), P. Mendes-Ferreira (Porto, Portugal), D. Santos-Ribeiro (Porto, Portugal), C. Maia-Rocha (Porto, Portugal), L. Pimentel (Porto, Portugal), C. Pinto (Porto, Portugal), E. Mulvaney (Dublin, Ireland), H. Reid (Dublin, Ireland), B. Kinsella (Dublin, Ireland), F. Potus (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), M. Rademaker (Christchurch, New Zealand), S. Provencher (Quebec, Canada), S. Bonnet (Quebec, Canada), A. Leite-Moreira (Porto, Portugal), C. Brás-Silva (Porto, Portugal)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)
A. Marra (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), C. Fischer (Heidelberg, Germany), H. Gall (Giessen, Germany), H. Ghofrani (Giessen, Germany), M. Halank (Dresden, Germany), M. Hoeper (Hannover, Germany), T. Lange (Regensburg, Germany), K. Olsson (Hannover, Germany), E. Grünig (Heidelberg, Germany)
Congress or journal article abstract
Congress or journal article abstract
Interim analysis of pulmonary arterial hypertension (PAH)-targeted background therapy in SPHERE (SelexiPag: tHe usErs dRug rEgistry)
V. McLaughlin (Ann Arbor, United States of America), K. Chin (Dallas, United States of America), H. Farber (Boston, United States of America), K. Highland (Cleveland, United States of America), A. Hemnes (Nashville, United States of America), M. Chakinala (St. Louis, United States of America), C. Zhao (South San Francisco, United States of America), M. Keating (South San Francisco, United States of America), N. Kim (San Diego, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
A. Jaureguizar Oriol (Madrid, Spain), E. Barbero Herranz (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), D. Barrios Barreto (Madrid, Spain), A. Román Broto (Barcelona, Spain), J. Segovia Cubero (Madrid, Spain), T. Elías Hernández (Sevilla, Spain), S. Cadenas Menéndez (Salamanca, Spain), P. Bedate Díaz (Asturias, Spain), I. Blanco Vich (Barcelona, Spain), P. Escribano Subías (Madrid, Spain)
Congress or journal article abstract
Congress or journal article abstract
Switching to macitentan in pulmonary arterial hypertension
I. Tsagkaris (Athens, Greece), E. Vrigkou (Athens, Greece), D. Konstantonis (Athens, Greece), F. Frantzeskaki (Athens, Greece), A. Pappas (Athens, Greece), K. Ntaï (Athens, Greece), E. Stagaki (Athens, Greece), A. Armaganidis (Athens, Greece), S. Orfanos (Athens, Greece)
Congress or journal article abstract
Congress or journal article abstract
A single-centre, placebo-controlled, double-blinded, randomized, cross-over study of Iloprost in patients with Eisenmenger syndrome
H. Nashat (London, United Kingdom), C. Harries (London, United Kingdom), L. Parfitt (London, United Kingdom), E. Shaw (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), M. Gatzoulis (London, United Kingdom), K. Dimopoulos (London, United Kingdom), S. Wort (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Differences in the activity of the angiotensin converting enzyme 2 axis in patients with idiopathic pulmonary arterial hypertension and congenital heart defect related pulmonary hypertension
J. Sandoval Zarate (Mexico City, Mexico), R. Teijeiro Paradis (Mexico City, Mexico), T. Pulido Zamudio (Mexico City, Mexico), N. Zayas Hernadnez (Mexico City, Mexico), L. Del Valle (Mexico City, Mexico), F. Massó (Mexico City, Mexico), H. Gonzalez (Mexico City, Mexico), C. Sisniega (Mexico City, Mexico), G. Pastelin (Mexico City, Mexico)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cough and airway irritation with inhaled treprostinil does not involve activation of laryngeal reflexes.
R. Chapman (Bridgewater, United States of America), W. Perkins (Bridgewater, United States of America), V. Malinin (Bridgewater, United States of America), D. Konicek (Bridgewater, United States of America), A. Plaunt (Bridgewater, United States of America), Z. Li (Bridgewater, United States of America), H. Gauani (Bridgewater, United States of America), A. Bouchard (Sherbrooke, QC, Canada), S. Gagnon (Sherbrooke, QC, Canada), L. Turcotte (Sherbrooke, QC, Canada), C. Laurent (Sherbrooke, QC, Canada), D. Salvail (Sherbrooke, QC, Canada), M. Corboz (Bridgewater, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
A. Kambakamba (Giessen, Germany), K. Tello (Giessen, Germany), J. Axmann (Giessen, Germany), H. Gall (Giessen, Germany), A. Ghofrani (Giessen, Germany), S. Guth (Bad Nauheim, Germany), C. Wiedenroth (Bad Nauheim, Germany), M. Richter (Giessen, Germany)
Congress or journal article abstract
Congress or journal article abstract
Efficacy and safety of tadalafil in portopulmonary hypertension
M. Jevnikar (Le Kremlin-Bicêtre, France), N. Ebstein (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France), A. Boucly (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France)
Congress or journal article abstract
Congress or journal article abstract
The effects of a 10-weeks-pulmonary rehabilitation program on exercise performance, muscle strength and quality of life in patients with pulmonary hypertension.
T. Koudstaal (Rotterdam, Netherlands), M. Wapenaar (Rotterdam, Netherlands), D. Van Ranst (Breda, Netherlands), R. Beesems (Breda, Netherlands), L. Van Den Toorn (Rotterdam, Netherlands), K. Boomars (Rotterdam, Netherlands)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
H. Nashat (London, United Kingdom), R. Da Costa (London, United Kingdom), J. Barbosa (London, United Kingdom), C. Harries (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), C. Mc Cabe (London, United Kingdom), M. Gatzoulis (London, United Kingdom), K. Dimopoulos (London, United Kingdom), S. Wort (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Initial dual oral combination therapy in inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
M. Gabrielly (Le Kremlin Bicêtre, France), D. Bourlier (Pessac, France), Y. Taniguchi (Le Kremlin Bicêtre, France), M. Jevnikar (Le Kremlin Bicêtre, France), A. Sekine (Le Kremlin Bicêtre, France), A. Boucly (Le Kremlin Bicêtre, France), E. Jutant (Le Kremlin Bicêtre, France), F. Parent (Le Kremlin Bicêtre, France), L. Savale (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France), G. Simonneau (Le Kremlin Bicêtre, France), M. Humbert (Le Kremlin Bicêtre, France), O. Sitbon (Le Kremlin Bicêtre, France), X. Jais (Le Kremlin Bicêtre, France)
Congress or journal article abstract
Congress or journal article abstract
Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan
N. Tanabe (Chiba, Japan), T. Ogo (Osaka, Japan), M. Hatano (Tokyo, Japan), Y. Tazaki (Osaka, Japan), T. Sunaya (Osaka, Japan), A. Saikawa (Osaka, Japan), T. Sakaguchi (Osaka, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
S. Fukui (Osaka, Japan), M. Palazzini (Bologna, Italy), E. Gotti (Bologna, Italy), D. Pacini (Bologna, Italy), S. Suarez (Bologna, Italy), T. Ogo (Osaka, Japan), S. Yasuda (Osaka, Japan), A. Manes (Bologna, Italy), N. Nakanishi (Osaka, Japan), N. Galié (Bologna, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster